Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403) - Concepedia

Concepedia

Publication | Open Access

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

DOI Full Paper Access

203

Citations

36

References

2008

Year

Kenji Tamura, Isamu Okamoto, Tatsuhiko Kashii, Shunichi Negoro, T. Hirashima, Satoshi Kudoh, Y. Ichinose, Noriyuki Ebi, Kazuhiko Shibata, Takashi Nishimura,

British Journal of Cancer

References

	Year	Citations

Page 1